Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denys Oliinyk

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Proteomics|October 27, 2022
Ion mobility-resolved phosphoproteomics with dia-PASEF and short gradientsDenys Oliinyk, Florian Meier
Analytical and Bioanalytical Chemistry|September 27, 2023
Peptide collision cross sections of 22 post-translational modificationsAndreas Will, Denys Oliinyk, Christian Bleiholder, et al.
Communications Biology|September 25, 2024
EXCRETE workflow enables deep proteomics of the microbial extracellular environmentDavid A Russo, Denys Oliinyk, Georg Pohnert, et al.
Molecular & Cellular Proteomics : MCP|March 5, 2025
diaPASEF Analysis for HLA-I Peptides Enables Quantification of Common Cancer NeoantigensDenys Oliinyk, Hem R Gurung, Zhenru Zhou, et al.
Pharmaceuticals (Basel, Switzerland)|August 29, 2024
Vorinostat Treatment of Gastric Cancer Cells Leads to ROS-Induced Cell Inhibition and a Complex Pattern of Molecular Alterations in Nrf2-Dependent GenesLeoni Lorenz, Tamara Zenz, Denys Oliinyk, et al.
Neoplasia (New York, N.Y.)|January 26, 2025
Acquired vulnerability against EGF receptor inhibition in gastric cancer promoted by class I histone deacetylase inhibitor entinostatTamara Zenz, Robert Jenke, Denys Oliinyk, et al.
Biochemical Pharmacology|May 5, 2024
HDAC inhibitors activate lipid peroxidation and ferroptosis in gastric cancerRobert Jenke, Denys Oliinyk, Tamara Zenz, et al.
Molecular Systems Biology|June 21, 2024
µPhos: a scalable and sensitive platform for high-dimensional phosphoproteomicsDenys Oliinyk, Andreas Will, Felix R Schneidmadel, et al.
Iscience|October 3, 2022
PD-1 expression on mouse intratumoral NK cells and its effects on NK cell phenotypeArnika K Wagner, Nadir Kadri, Chris Tibbitt, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Reprogramming insulin receptor activation with a de novo agonist to overcome severe insulin resistanceAlbert Hung, Xinru Wang, Michael Gao, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Proteomics|October 27, 2022
Ion mobility-resolved phosphoproteomics with dia-PASEF and short gradientsDenys Oliinyk, Florian Meier
Analytical and Bioanalytical Chemistry|September 27, 2023
Peptide collision cross sections of 22 post-translational modificationsAndreas Will, Denys Oliinyk, Christian Bleiholder, et al.
Communications Biology|September 25, 2024
EXCRETE workflow enables deep proteomics of the microbial extracellular environmentDavid A Russo, Denys Oliinyk, Georg Pohnert, et al.
Molecular & Cellular Proteomics : MCP|March 5, 2025
diaPASEF Analysis for HLA-I Peptides Enables Quantification of Common Cancer NeoantigensDenys Oliinyk, Hem R Gurung, Zhenru Zhou, et al.
Pharmaceuticals (Basel, Switzerland)|August 29, 2024
Vorinostat Treatment of Gastric Cancer Cells Leads to ROS-Induced Cell Inhibition and a Complex Pattern of Molecular Alterations in Nrf2-Dependent GenesLeoni Lorenz, Tamara Zenz, Denys Oliinyk, et al.
Neoplasia (New York, N.Y.)|January 26, 2025
Acquired vulnerability against EGF receptor inhibition in gastric cancer promoted by class I histone deacetylase inhibitor entinostatTamara Zenz, Robert Jenke, Denys Oliinyk, et al.
Biochemical Pharmacology|May 5, 2024
HDAC inhibitors activate lipid peroxidation and ferroptosis in gastric cancerRobert Jenke, Denys Oliinyk, Tamara Zenz, et al.
Molecular Systems Biology|June 21, 2024
µPhos: a scalable and sensitive platform for high-dimensional phosphoproteomicsDenys Oliinyk, Andreas Will, Felix R Schneidmadel, et al.
Iscience|October 3, 2022
PD-1 expression on mouse intratumoral NK cells and its effects on NK cell phenotypeArnika K Wagner, Nadir Kadri, Chris Tibbitt, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Reprogramming insulin receptor activation with a de novo agonist to overcome severe insulin resistanceAlbert Hung, Xinru Wang, Michael Gao, et al.
Pageof 2